Safyral FDA Approval History
FDA Approved: Yes (First approved December 16, 2010)
Brand name: Safyral
Generic name: drospirenone, ethinyl estradiol and levomefolate calcium
Dosage form: Tablets
Company: Bayer HealthCare Pharmaceuticals, Inc.
Treatment for: Birth Control
Safyral (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, and to raise folate levels in women who choose to use an oral contraceptive for contraception.
Development Timeline for Safyral
|Dec 17, 2010||FDA Approves Safyral - Oral Contraceptive That Also Raises Folate Levels|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.